cost-effectiveness

Department

Off-Label Immunotherapy Prescriptions Common, Expensive

04/12/2017

JCP Editors

Many patients receive immunotherapy prescriptions for off-label treatment, potentially contributing to unnecessary health care expenditures.  ----- Related Content Cost-Effective Immunotherapy Treatments for...

Many...

04/12/2017

Journal of Clinical Pathways

Quiz

Quiz: Projected Outcomes of Using Oral Targeted Therapies for CLL

01/12/2017

JCP Editors

Use of oral targeted therapies for patients with chronic lymphocytic leukemia (CLL) is projected to have which result?   A)      Improved...

Use of...

01/12/2017

Journal of Clinical Pathways

Research in Review

A Road Map for Using Biomarkers in Clinical Practice

12/16/2016

JCP Editors

New consensus guidelines provide a "road map" for the appropriate implementation of imaging biomarkers in clinical practice. ----- Related Content Biomarkers Predict Cetuximab Performance in Metastatic Colorectal...

New...

12/16/2016

Journal of Clinical Pathways

Pharma Insights

When Medication Price Deflates Perception of Therapeutic Effect

04/11/2016

Larry Blandford, PharmD—Column Editor

Stephen C Carter

Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...

...

04/11/2016

Journal of Clinical Pathways